Two Sigma Securities’s Heart Test Laboratories HSCS Stock Holding History

Two Sigma Securities’s Portfolio HSCS Stock Details HSCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-505	Closed	-$5.91K	–	3275
2024 Q1	$5.91K	Buy	505 +197	+64%	+$2.58K	﹤0.01%	2819
2023 Q4	$5.27K	Buy	+308	New	+$7.59K	﹤0.01%	2877
2023 Q3	–	Sell	-174	Closed	-$15.8K	–	3170
2023 Q2	$15.8K	Buy	174 +61	+54%	+$5.96K	﹤0.01%	2537
2023 Q1	$11.1K	Buy	+113	New	+$15.3K	﹤0.01%	2441

Other funds holding HSCS

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cultivar Capital Denton, Texas $155M AUM 16.34% 1-Year Est. Return

OLVIG

Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Securities's HSCS Position: Q2 2024 in Review

Two Sigma Securities sold out of Heart Test Laboratories (HSCS) in Q2 2024, closing a stake of 505 shares — an estimated $5.91K sold.

Two Sigma Securities first reported a position in HSCS in Q1 2023 and held it in 4 quarters. The position peaked at $15.8K in Q2 2023. 7 funds tracked by Wall St. Rank hold HSCS as of Q2 2024.

Two Sigma Securities reported no remaining Heart Test Laboratories position as of Q2 2024 after selling out during the quarter.
Two Sigma Securities sold 505 Heart Test Laboratories shares in Q2 2024, an estimated $5.91K.
Two Sigma Securities first reported a position in Heart Test Laboratories in Q1 2023 and held it in 4 quarters.
Two Sigma Securities's Heart Test Laboratories position peaked at $15.8K in Q2 2023.
7 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.